For example, Lamp2b can fuse with an anti-HER2 nanobody and direct exosomes to HER2-overexpressing breast cancer cells, while exosomes displaying anti-EGFR nanobody are found to suppress EGFR signaling and reduce proliferation in triple negative breast cancer cells [43]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.